CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
8.70
-0.40 (-4.40%)
May 13, 2025, 4:00 PM - Market closed

CervoMed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
761943--
Market Cap Growth
-44.61%-55.39%---
Enterprise Value
40-2733--
Last Close Price
8.702.347.63--
PS Ratio
8.141.986.06--
PB Ratio
2.190.495.87--
P/TBV Ratio
2.190.495.87--
EV/Sales Ratio
4.35-4.60--
Debt / Equity Ratio
----1.38-2.74
Asset Turnover
0.400.371.01--
Quick Ratio
9.3510.613.360.311.48
Current Ratio
9.7811.113.840.321.50
Return on Equity (ROE)
-93.42%-69.95%---
Return on Assets (ROA)
-56.19%-42.95%-69.12%-39.59%-
Return on Capital (ROIC)
-65.47%-48.91%-90.49%-44.40%-
Earnings Yield
-24.66%-84.35%-5.02%--
Buyback Yield / Dilution
-113.67%-203.34%-413.65%88.49%-
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q